Top 4 Stocks In The Drug Delivery Industry With The Highest Revenue

Below are the drug delivery stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Valeant Pharmaceuticals International

is $8.04 billion. Valeant Pharmaceuticals' ROE for the same period is 9.77%. The trailing-twelve-month revenue at Alkermes plc

is $578.99 million. Alkermes' PEG ratio is 5.67. The trailing-twelve-month revenue at PetMed Express

is $228.84 million. PetMed Express' EPS for the same period is $0.84. The trailing-twelve-month revenue at Columbia Laboratories

is $33.19 million. Columbia Laboratories' operating margin for the same period is 16.23%.